References

References:

  1. Chen H, Li P, Xie Y, Jin M. Cytology and clinical features of myelomatous pleural effusion: Three case reports and a review of the literature. Diagn Cytopathol. Jul 2018;46(7):604-609. doi:10.1002/dc.23894
  2. Harbhajanka A, Brickman A, Park JW, Reddy VB, Bitterman P, Gattuso P. Cytomorphology, clinicopathologic, and cytogenetics correlation of myelomatous effusion of serous cavities: A retrospective review. Diagn Cytopathol. Sep 2016;44(9):742-7. doi:10.1002/dc.23523
  3. Kim YJ, Kim SJ, Min K, et al. Multiple myeloma with myelomatous pleural effusion: a case report and review of the literature. Acta Haematol. 2008;120(2):108-11. doi:10.1159/000165694
  4. Sasser RL, Yam LT, Li CY. Myeloma with involvement of the serous cavities. Cytologic and immunochemical diagnosis and literature review. Acta Cytol. Jul-Aug 1990;34(4):479-85.
  5. Cho YU, Chi HS, Park CJ, Jang S, Seo EJ, Suh C. Myelomatous pleural effusion: a case series in a single institution and literature review. Korean J Lab Med. Oct 2011;31(4):225-30. doi:10.3343/kjlm.2011.31.4.225
  6. Ulubay G, Eyuboglu FO, Simsek A, Ozyilkan O. Multiple myeloma with pleural involvement: a case report. Am J Clin Oncol. Aug 2005;28(4):429-30. doi:10.1097/01.coc.0000144816.97535.31
  7. Palmer HE, Wilson CS, Bardales RH. Cytology and flow cytometry of malignant effusions of multiple myeloma. Diagn Cytopathol. Mar 2000;22(3):147-51. doi:10.1002/(sici)1097-0339(20000301)22:3<147::aid-dc3>3.0.co;2-6
  8. Ghorbel IB, Feki NB, Lamloum M, et al. Pleural myelomatous involvement in multiple myeloma: five cases. Ann Saudi Med. Jul-Aug 2015;35(4):327-30. doi:10.5144/0256-4947.2015.327
  9. Lin P, Owens R, Tricot G, Wilson CS. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol. Apr 2004;121(4):482-8. doi:10.1309/74R4-TB90-BUWH-27JX
  10. Wang Z, Xia G, Lan L, et al. Pleural Effusion in Multiple Myeloma. Intern Med. 2016;55(4):339-45. doi:10.2169/internalmedicine.55.4733
  11. Shaughnessy JD, Jr., Zhan F, Burington BE, et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood. Mar 15 2007;109(6):2276-84. doi:10.1182/blood-2006-07-038430